Multi-dose Vials

• 83-amino acid analog with enhanced potency (~3x native IGF-1) and extended half-life (20-30 hours)
• Engineered for reduced IGFBP binding, allowing sustained IGF-1R activation without sequestration
• Validated in 22+ publications across cardiovascular, fetal growth, gastrointestinal, and cell culture research

Ipamorelinis a synthetic pentapeptide growth hormone secretagogue that selectively binds the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor. In experimental models, Ipamorelin activates Gq/PLC-dependent calcium signaling pathways that stimulate growth hormone release while demonstrating minimal activity on other pituitary hormones, including ACTH, prolactin, FSH, LH, TSH, and cortisol. Due to its high receptor selectivity, Ipamorelin is widely utilized in rese

• Quad-Peptide Blend: BPC-157 10mg + TB-500 10mg + GHK-Cu 50mg + KPV 10mg (80mg total)
• Enhanced Anti-Inflammatory: KPV addition for NF-κB pathway inhibition and cytokine control
• Comprehensive Regeneration: Cytoprotection, angiogenesis, collagen synthesis, and inflammation modulation

• Master Antioxidant Tripeptide: L-γ-Glu-L-Cys-Gly sequence, ≥98% purity
• Cellular Redox Homeostasis: Primary intracellular thiol buffer (0.5-10 mM)
• Phase II Detoxification: GST-mediated conjugation and xenobiotic metabolism studies

Lipo-C (10ml)

• Profile: grade lipotropic complex containing L-Carnitine, L-Arginine, methionine, inositol, choline, and B-vitamins for laboratory studies
• Applications: Mitochondrial β-oxidation and fatty acid transport mechanism studies via carnitine palmitoyltransferase shuttle system
• Quality: >=95% Purity (HPLC Verified)

• Universal Redox Coenzyme: Central to 500+ enzymatic reactions, glycolysis, citric acid cycle, electron transport chain, 80,000+ PubMed publications since 1906 discovery
• Sirtuin/PARP/CD38 Substrate: Essential cofactor for SIRT1-7 longevity proteins, PARPs for DNA repair, CD38 calcium signaling; NAD+ declines 10-65% with aging across tissues
• Clinical Development: Multiple Phase 2 RCTs showing 2.6-3.1x NAD+ increases with precursor supplementation, benefits in metabolic disease, cognition, long COVID, well-tolerated safety profile